What is the price target for NZM2 stock?
24 analysts have analysed NZM2.DE and the average price target is 62.79 EUR. This implies a price increase of 22.84% is expected in the next year compared to the current price of 51.12.
NOVONESIS (NOVOZYMES) B (NZM2.DE) Forecast, Price Target & Analyst Ratings
FRA:NZM2 • DK0060336014
Current stock price
51.12 EUR
+0.42 (+0.83%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NOVONESIS (NOVOZYMES) B (NZM2.DE).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 5, 2026
- Period
- Q1 / 2026
- EPS Estimate
- €0.56
- Revenue Estimate
- 1.102B
Price Target Details & History
Consensus Price Target and Range
Mean target
€62.79
Upside
+ 22.84%
From current price of €51.12 to mean target of €62.79, Based on 24 analyst forecasts
Low
€51.47
Median
€63.61
High
€78.85
Price Target Revisions
1 Month
-1.50%
3 Months
-3.05%
Price Target Summary
24 Wall Street analysts provided a forecast for the next 12 months for NZM2.DE. The average price target is 62.79 EUR. This implies a price increase of 22.84% is expected in the next year compared to the current price of 51.12.
The average price target has been revised downward by 3.05% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
79.17%
NZM2.DE was analyzed by 24 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about NZM2.DE.
In the last month the buy percentage rose by 6 points. So the trust of analysts is improving.
NZM2.DE was analyzed by 24 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 5, 2026
- Period
- Q1 / 2026
- EPS Estimate
- €0.56
- Revenue Estimate
- 1.102B
- Revenue Q2Q
- 2.26%
- EPS Q2Q
- 33.95%
- Number of Analysts
- 2
Next Earnings Revisions
Revenue (1 Month)
3.47%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A
Next Earnings Summary
NZM2.DE is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.56 EUR and the consensus revenue estimate is 1.10B EUR.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.396B 1.91% | 3.834B 60.01% | 4.158B 8.45% | 4.472B 7.56% | 4.796B 7.25% | 5.141B 7.19% | 5.431B 5.64% | 5.787B 6.55% | 5.865B 1.35% | 6.153B 4.91% | 6.443B 4.71% | |
| EBITDA YoY % growth | 783.443M -1.54% | 1.256B 60.37% | 1.502B 19.52% | 1.672B 11.35% | 1.824B 9.09% | 1.968B 7.89% | 2.13B 8.23% | 2.3B 7.98% | 2.405B 4.57% | 2.538B 5.53% | 2.675B 5.40% | |
| EBIT YoY % growth | 597.521M 0.12% | 659M 10.29% | 904.7M 37.28% | 1.11B 22.69% | 1.245B 12.16% | 1.394B 11.97% | 1.449B 3.95% | 1.557B 7.45% | 1.668B 7.13% | 1.751B 4.98% | 1.833B 4.68% | |
| Operating Margin | 24.94% | 17.19% | 21.76% | 24.82% | 25.96% | 27.12% | 26.68% | 26.91% | 28.44% | 28.46% | 28.45% | |
| EPS YoY % growth | 1.46 -17.70% | N/A -10.56% | 1.88 43.90% | 2.02 7.60% | 2.24 10.77% | 2.43 8.24% | 2.71 11.59% | 2.97 9.87% | 3.08 3.45% | 3.25 5.61% | 3.44 5.94% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.56 33.95% | 0.54 15.18% | 0.57 5.68% | 0.54 20.30% |
| Revenue Q2Q % growth | 1.102B 2.26% | 1.095B 7.51% | 1.102B 3.48% | 1.057B 6.06% |
| EBITDA Q2Q % growth | 418.65M 2.09% | N/A | N/A | N/A |
| EBIT Q2Q % growth | 253.51M -8.05% | N/A | N/A | N/A |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
8.86%
EPS Next 5 Year
9.60%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
7.11%
Revenue Next 5 Year
6.70%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
26.68%
EBIT Next 5 Year
18.90%
NOVONESIS (NOVOZYMES) B / NZM2.DE Forecast FAQ
What is the next earnings date for NZM2 stock?
NOVONESIS (NOVOZYMES) B (NZM2.DE) will report earnings on 2026-05-05.
What are the consensus estimates for NOVONESIS (NOVOZYMES) B (NZM2.DE) next earnings?
The consensus EPS estimate for the next earnings of NOVONESIS (NOVOZYMES) B (NZM2.DE) is 0.56 EUR and the consensus revenue estimate is 1.10B EUR.
What is the consensus rating for NOVONESIS (NOVOZYMES) B (NZM2.DE) stock?
The consensus rating for NOVONESIS (NOVOZYMES) B (NZM2.DE) is 79.1667 / 100 . This indicates that analysts generally have a positive outlook on the stock.